Entrada Therapeutics, Inc. (TRDA) SEC filings
TRDA SEC filings moved a median of +0.44% by the close. TRDA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the TRDA overview →
59 measured TRDA SEC filing events.
Where these TRDA SEC filings landedvs 59 measured TRDA SEC filing reactions
| Middle 50% of TRDA SEC filing reactions | -1.56% to +3.60% |
|---|---|
| Median reaction (to close) | +0.44% |
| Measured reactions | 59 |
Point-in-time · zero look-ahead
Half of the 59 TRDA SEC filing events with a measured close landed between -1.56% and +3.60%; 51% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Entrada Therapeutics, For: Oct 14 | SEC filing · Form 8-K | +0.85% | -2.98% | |
| Form 10-Q Entrada Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.08% | -5.49% | |
| Form 8-K Entrada Therapeutics, For: Aug 05 | SEC filing · Form 8-K | -3.08% | -5.49% | |
| Form 8-K Entrada Therapeutics, For: Jun 10 | SEC filing · Form 8-K | -1.17% | +5.70% | |
| Form 8-K Entrada Therapeutics, For: May 18 | SEC filing · Form 8-K | -3.08% | -3.58% | |
| Form 10-Q Entrada Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -14.81% | +0.44% | |
| Form 8-K Entrada Therapeutics, For: May 07 | SEC filing · Form 8-K | -14.81% | +0.44% | |
| Form DEFA14A Entrada Therapeutics, | SEC filing · Form DEFA14A | +0.16% | -0.23% | |
| Form ARS Entrada Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.29% | -1.56% | |
| Form DEF 14A Entrada Therapeutics, For: Jun 10 | SEC filing · Form DEF | -1.29% | -1.56% | |
| Form DEFA14A Entrada Therapeutics, | SEC filing · Form DEFA14A | -1.29% | -1.56% | |
| Form 10-K Entrada Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.09% | +10.35% | |
| Form 8-K Entrada Therapeutics, For: Feb 26 | SEC filing · Form 8-K | -0.09% | +10.35% | |
| Form S-8 Entrada Therapeutics, | SEC filing · Form S-8 | -0.09% | +10.35% | |
| Form 8-K Entrada Therapeutics, For: Jan 08 | SEC filing · Form 8-K | +0.66% | -0.76% | |
| Form EFFECT Entrada Therapeutics, | SEC filing · Form EFFECT | -2.21% | +2.21% | |
| Form 10-Q Entrada Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.84% | +2.21% | |
| Form 8-K Entrada Therapeutics, For: Nov 06 | SEC filing · Form 8-K | -1.84% | +2.21% | |
| Form S-3 Entrada Therapeutics, | SEC filing · Form S-3 | -1.84% | +2.21% | |
| Form 10-Q Entrada Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.24% | +4.94% | |
| Form 8-K Entrada Therapeutics, For: Aug 06 | SEC filing · Form 8-K | -1.24% | +4.94% | |
| Form 8-K Entrada Therapeutics, For: Jun 11 | SEC filing · Form 8-K | -0.06% | -0.51% | |
| Form 8-K Entrada Therapeutics, For: May 30 | SEC filing · Form 8-K | -0.80% | +1.98% | |
| Form DEFA14A Entrada Therapeutics, | SEC filing · Form DEFA14A | -0.80% | +1.98% | |
| Form 10-Q Entrada Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +4.63% | +6.42% | |
| Form 8-K Entrada Therapeutics, For: May 08 | SEC filing · Form 8-K | +4.63% | +6.42% | |
| Form 8-K Entrada Therapeutics, For: Apr 29 | SEC filing · Form 8-K | -0.91% | +4.11% | |
| Form ARS Entrada Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.79% | -0.45% | |
| Form DEF 14A Entrada Therapeutics, For: Jun 11 | SEC filing · Form DEF | -0.79% | -0.45% | |
| Form DEFA14A Entrada Therapeutics, | SEC filing · Form DEFA14A | -0.79% | -0.45% | |
| Form S-8 Entrada Therapeutics, | SEC filing · Form S-8 | +0.00% | -5.44% | |
| Form 8-K Entrada Therapeutics, For: Mar 24 | SEC filing · Form 8-K | +0.00% | +1.60% | |
| Form 10-K Entrada Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.37% | -1.88% | |
| Form 8-K Entrada Therapeutics, For: Feb 27 | SEC filing · Form 8-K | +0.37% | -1.88% | |
| Form S-8 Entrada Therapeutics, | SEC filing · Form S-8 | +0.37% | -1.88% | |
| Form 8-K Entrada Therapeutics, For: Feb 24 | SEC filing · Form 8-K | +1.54% | -5.58% | |
| Form 8-K Entrada Therapeutics, For: Feb 03 | SEC filing · Form 8-K | -0.70% | +3.73% | |
| Form 8-K Entrada Therapeutics, For: Jan 15 | SEC filing · Form 8-K | +1.49% | +3.46% | |
| Form 10-Q Entrada Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -2.77% | +3.16% | |
| Form 8-K Entrada Therapeutics, For: Nov 05 | SEC filing · Form 8-K | -2.77% | +3.16% | |
| Form 10-Q Entrada Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -7.83% | -0.75% | |
| Form 8-K Entrada Therapeutics, For: Aug 13 | SEC filing · Form 8-K | -7.83% | -0.75% | |
| Form 8-K Entrada Therapeutics, For: Jun 24 | SEC filing · Form 8-K | +1.13% | -5.13% | |
| Form 8-K Entrada Therapeutics, For: Jun 13 | SEC filing · Form 8-K | +0.31% | -1.38% | |
| Form 10-Q Entrada Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.07% | +0.65% | |
| Form 8-K Entrada Therapeutics, For: May 07 | SEC filing · Form 8-K | +0.07% | +0.65% | |
| Form ARS Entrada Therapeutics, For: Dec 31 | SEC filing · Form ARS | — | -1.04% | |
| Form DEF 14A Entrada Therapeutics, For: Jun 13 | SEC filing · Form DEF | — | -1.04% | |
| Form DEFA14A Entrada Therapeutics, | SEC filing · Form DEFA14A | — | -1.04% | |
| Form PRE 14A Entrada Therapeutics, For: Jun 13 | SEC filing · Form PRE | +0.00% | +2.71% | |
| Form 10-K Entrada Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -1.16% | +5.13% | |
| Form 8-K Entrada Therapeutics, For: Mar 13 | SEC filing · Form 8-K | -1.16% | +5.13% | |
| Form S-8 Entrada Therapeutics, | SEC filing · Form S-8 | -1.16% | +5.13% | |
| Form 8-K Entrada Therapeutics, For: Dec 29 | SEC filing · Form 8-K | +0.00% | -9.69% | |
| Form 8-K Entrada Therapeutics, For: Dec 05 | SEC filing · Form 8-K | +0.00% | -2.62% | |
| Form 8-K Entrada Therapeutics, For: Nov 22 | SEC filing · Form 8-K | -2.70% | -28.55% | |
| Form 10-Q Entrada Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +5.46% | |
| Form 8-K Entrada Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +0.00% | +5.46% | |
| Form 8-K Entrada Therapeutics, For: Oct 26 | SEC filing · Form 8-K | +0.00% | -2.27% |
Keep exploring
More TRDA: earnings → · analyst actions → · TRDA overview →